GEHC
GE HealthCare Technologies Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
-18/100
Last price
65.09
▼ 0.65 (0.99%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
65.74
Prev close
65.74
Day high
66.55
Day low
64.67
Volume
3.55M
Market cap
$29.26B
P/E (TTM)
15.10
52W range
58.75 – 89.77
Day trading desk
Gap from prior close
+0.00%
Prior close 65.74
VWAP
65.16
-0.10% from price
Relative volume
0.55×
Quiet session
Session range
2.91%
64.67 – 66.55
Position in range
22%
Near session low
ATR (14D)
1.48
2.27% of price
Prior day high
65.86
PDH
Prior day low
63.37
PDL
Bid / ask spread
—
Quote not published
Session volume
2.24M
Avg 4.08M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.54%
-4.5%
1M
-5.94%
-7.1%
3M
+0.14%
-4.4%
6M
-7.11%
-25.3%
YTD
-21.03%
-35.3%
1Y
-15.40%
-31.8%
3Y
-4.81%
-87.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on GEHC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.67M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 14, 26 | GROGAN WILLIAM K. Chief Financial Officer |
STOCK | 75.10K | $0 | Direct |
| May 22, 26 | LOBO KEVIN A Director |
BUY | 10.00K | $641.80K | Direct |
| May 12, 26 | HOCHMAN RODNEY F Director |
BUY | 1.62K | $100.36K | Indirect |
| May 8, 26 | YANG WATKIN PHOEBE L Director |
BUY | 1.00K | $63.01K | Direct |
| May 7, 26 | HOCHMAN RODNEY F Director |
STOCK | 6.28K | $0 | Direct |
| May 7, 26 | LOBO KEVIN A Director |
STOCK | 3.59K | $0 | Direct |
| May 7, 26 | MADDEN ANNE T Director |
STOCK | 5.87K | $0 | Direct |
| May 7, 26 | CULP HENRY LAWRENCE JR. Director |
STOCK | 7.74K | $0 | Direct |
| May 7, 26 | STROMBERG WILLIAM J Director |
STOCK | 3.59K | $0 | Direct |
| May 7, 26 | LESJAK CATHERINE ANNE Director |
STOCK | 3.59K | $0 | Direct |
| May 7, 26 | YANG WATKIN PHOEBE L Director |
STOCK | 3.59K | $0 | Direct |
| May 6, 26 | CULP HENRY LAWRENCE JR. Director |
BUY | 80.81K | $5.00M | Indirect |
| May 6, 26 | STROMBERG WILLIAM J Director |
BUY | 1.00K | $61.69K | Direct |
| May 1, 26 | SACCARO JAMES Chief Financial Officer |
BUY | 3.31K | $200.59K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ARDUINI PETER J |
Chief Executive Officer | 259.42K | Purchase |
BANKES JEANNETTE |
Officer | 43.89K | Stock Award(Grant) |
CULP HENRY LAWRENCE JR. |
Director | 499.92K | Stock Award(Grant) |
GROGAN WILLIAM K. |
Chief Financial Officer | 75.10K | Stock Award(Grant) |
JIMENEZ FRANK R |
General Counsel | 93.93K | Purchase |
KASS-HOUT TAHA |
Chief Technology Officer | 92.91K | Stock Award(Grant) |
O'NEILL KEVIN MICHAEL |
Officer | 32.80K | Stock Award(Grant) |
ROTT ROLAND |
Officer | 41.08K | Stock Award(Grant) |
SACCARO JAMES |
Chief Financial Officer | 87.47K | Purchase |
STACHERSKI KENNETH ROBERT |
Officer | 41.89K | Stock Award(Grant) |
Fundamentals
Market cap$29.26B
Enterprise value$37.96B
Revenue (TTM)$21.27B
Gross profit$8.41B
EBITDA$3.59B
Net income$1.98B
EPS (TTM)$4.29
Free cash flow$1.57B
Total cash$2.08B
Total debt$10.54B
Book value / share$24.30
Shares outstanding451.69M
Float450.20M
Short % of float4.24%
Dividend yield0.24%
Beta (5Y)0.85
Valuation & profitability ratios
Trailing P/E15.10
Forward P/E11.97
PEG ratio1.64
Price / sales—
Price / book2.67
EV / revenue1.79
EV / EBITDA10.57
Gross margin39.53%
Operating margin14.98%
Profit margin9.33%
Return on equity19.38%
Return on assets5.13%
Debt / equity93.97
Current ratio1.26
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $20.63B | $19.67B | $19.55B | $18.34B | +4.8% |
| Operating revenue | $20.63B | $19.67B | $19.55B | $18.34B | +4.8% |
| Cost of revenue | $12.38B | $11.47B | $11.63B | $11.16B | +7.9% |
| Gross profit | $8.25B | $8.21B | $7.92B | $7.18B | +0.5% |
| Research & development | $1.26B | $1.31B | $1.21B | $1.03B | -3.9% |
| Selling, general & admin | $4.22B | $4.27B | $4.28B | $3.63B | -1.0% |
| Total operating expense | $5.49B | $5.58B | $5.49B | $4.66B | -1.7% |
| Operating income | $2.76B | $2.63B | $2.44B | $2.52B | +5.2% |
| Net interest income | -$399.00M | -$505.00M | -$516.00M | -$86.00M | +21.0% |
| Pre-tax income | $2.77B | $2.58B | $2.36B | $2.51B | +7.2% |
| Tax provision | $614.00M | $531.00M | $743.00M | $563.00M | +15.6% |
| Net income | $2.08B | $1.99B | $1.57B | $1.92B | +4.6% |
| Net income to common | $2.08B | $1.99B | $1.39B | $1.92B | +4.6% |
| Basic EPS | 4.56 | 4.37 | 3.05 | 4.63 | +4.3% |
| Diluted EPS | 4.55 | 4.34 | 3.03 | 4.63 | +4.8% |
| EBIT | $3.21B | $3.09B | $2.90B | $2.60B | +4.0% |
| EBITDA | $3.79B | $3.67B | $3.51B | $3.23B | +3.3% |
| Basic shares | 456.00M | 456.00M | 455.00M | 413.82M | 0.0% |
| Diluted shares | 458.00M | 459.00M | 458.00M | 413.82M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.49B | $2.87B | $2.49B | $1.44B | +56.3% |
| Cash & short-term investments | $4.49B | $2.87B | $2.49B | $1.44B | +56.3% |
| Accounts receivable | $3.72B | $3.38B | $3.34B | $3.11B | +10.0% |
| Inventory | $2.23B | $1.94B | $1.96B | $2.15B | +15.2% |
| Total current assets | $12.50B | $9.90B | $9.41B | $8.32B | +26.3% |
| Property, plant & equipment | $3.09B | $2.55B | $2.50B | $2.31B | +21.2% |
| Goodwill & intangibles | $14.62B | $14.21B | $14.19B | $14.33B | +2.8% |
| Total assets | $36.91B | $33.09B | $32.45B | $27.54B | +11.5% |
| Total current liabilities | $9.11B | $9.55B | $8.98B | $7.19B | -4.7% |
| Current debt | $508.00M | $1.50B | $1.01B | $15.00M | -66.2% |
| Long-term debt | $9.49B | $7.45B | $8.44B | $8.23B | +27.5% |
| Total debt | $10.46B | $9.38B | $9.86B | $8.63B | +11.6% |
| Total liabilities | $26.31B | $24.44B | $25.14B | $17.95B | +7.7% |
| Retained earnings | $5.28B | $3.26B | $1.33B | $0 | +61.9% |
| Shareholder equity | $10.38B | $8.45B | $7.13B | $9.36B | +22.9% |
| Working capital | $3.40B | $348.00M | $429.00M | $1.13B | +875.9% |
| Net tangible assets | -$4.24B | -$5.77B | -$7.06B | -$4.98B | +26.5% |
| Shares issued | 458.84M | 457.25M | 455.34M | 454.00M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.15B | $2.05B | $1.62B | $1.95B | +5.1% |
| Depreciation & amortisation | $578.00M | $580.00M | $610.00M | $633.00M | -0.3% |
| Stock-based compensation | $130.00M | $125.00M | $114.00M | $67.00M | +4.0% |
| Change in working capital | -$153.00M | -$68.00M | $27.00M | -$293.00M | -125.0% |
| Operating cash flow | $1.99B | $1.95B | $2.10B | $2.11B | +1.8% |
| Capital expenditure | -$482.00M | -$401.00M | -$387.00M | -$310.00M | -20.2% |
| Investing cash flow | -$1.05B | -$914.00M | -$558.00M | -$398.00M | -14.6% |
| Share buybacks | -$200.00M | $0 | $0 | — | — |
| Dividends paid | -$64.00M | -$55.00M | -$41.00M | $0 | -16.4% |
| Financing cash flow | $617.00M | -$573.00M | -$478.00M | -$822.00M | +207.7% |
| Free cash flow | $1.50B | $1.55B | $1.71B | $1.80B | -2.9% |
| End cash position | $4.51B | $2.89B | $2.51B | $1.45B | +56.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $5.29B | $5.13B | $5.70B | $5.14B | $5.01B | +3.2% |
| Operating revenue | $5.29B | $5.13B | $5.70B | $5.14B | $5.01B | +3.2% |
| Cost of revenue | $3.12B | $3.15B | $3.44B | $3.15B | $3.02B | -1.2% |
| Gross profit | $2.18B | $1.98B | $2.26B | $1.99B | $1.98B | +10.2% |
| Research & development | $323.00M | $345.00M | $323.00M | $292.00M | $302.00M | -6.4% |
| Selling, general & admin | $1.12B | $1.12B | $1.11B | $1.04B | $1.03B | +0.1% |
| Total operating expense | $1.44B | $1.46B | $1.43B | $1.34B | $1.33B | -1.4% |
| Operating income | $738.00M | $515.00M | $827.00M | $653.00M | $652.00M | +43.3% |
| Net interest income | -$107.00M | -$97.00M | -$81.00M | -$99.00M | -$107.00M | -10.3% |
| Pre-tax income | $693.00M | $505.00M | $821.00M | $643.00M | $613.00M | +37.2% |
| Tax provision | $119.00M | $94.00M | $219.00M | $179.00M | $113.00M | +26.6% |
| Net income | $560.00M | $389.00M | $589.00M | $446.00M | $486.00M | +44.0% |
| Net income to common | $561.00M | $389.00M | $589.00M | $446.00M | $486.00M | +44.2% |
| Basic EPS | 1.24 | 0.85 | 1.29 | 0.98 | 1.06 | +45.9% |
| Diluted EPS | 1.24 | 0.85 | 1.29 | 0.98 | 1.06 | +45.9% |
| EBIT | $807.00M | $602.00M | $926.00M | $754.00M | $726.00M | +34.1% |
| EBITDA | $967.00M | $755.00M | $1.07B | $902.00M | $874.00M | +28.1% |
| Basic shares | 453.00M | 456.00M | 456.00M | 456.00M | 457.00M | -0.7% |
| Diluted shares | 454.00M | 457.00M | 457.00M | 457.00M | 458.00M | -0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.08B | $2.26B | $4.49B | $4.00B | $3.74B | -8.0% |
| Cash & short-term investments | $2.08B | $2.26B | $4.49B | $4.00B | $3.74B | -8.0% |
| Accounts receivable | $3.54B | $3.46B | $3.72B | $3.47B | $3.34B | +2.0% |
| Inventory | $2.48B | $2.35B | $2.23B | $2.30B | $2.28B | +5.5% |
| Total current assets | $10.50B | $10.43B | $12.50B | $11.89B | $11.31B | +0.7% |
| Property, plant & equipment | $3.15B | $3.10B | $3.09B | $3.01B | $2.96B | +1.7% |
| Goodwill & intangibles | $16.99B | $16.97B | $14.62B | $14.60B | $14.64B | +0.1% |
| Total assets | $37.25B | $37.13B | $36.91B | $36.13B | $35.50B | +0.3% |
| Total current liabilities | $8.30B | $8.53B | $9.11B | $10.07B | $9.75B | -2.7% |
| Current debt | $2.00M | $7.00M | $508.00M | $2.00B | $2.00B | -71.4% |
| Long-term debt | $10.09B | $10.13B | $9.49B | $8.28B | $8.27B | -0.4% |
| Total debt | $10.54B | $10.58B | $10.46B | $10.74B | $10.72B | -0.3% |
| Total liabilities | $26.03B | $26.23B | $26.31B | $25.91B | $25.55B | -0.8% |
| Retained earnings | $6.20B | $5.65B | $5.28B | $4.71B | $4.29B | +9.6% |
| Shareholder equity | $10.97B | $10.67B | $10.38B | $9.99B | $9.71B | +2.9% |
| Working capital | $2.19B | $1.90B | $3.40B | $1.82B | $1.56B | +15.7% |
| Net tangible assets | -$6.01B | -$6.30B | -$4.24B | -$4.61B | -$4.92B | +4.5% |
| Shares issued | 451.69M | 459.40M | 458.84M | 458.62M | 458.28M | -1.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $574.00M | $411.00M | $602.00M | $464.00M | $500.00M | +39.7% |
| Depreciation & amortisation | $160.00M | $153.00M | $146.00M | $148.00M | $148.00M | +4.6% |
| Stock-based compensation | $45.00M | $35.00M | $36.00M | $38.00M | $34.00M | +28.6% |
| Change in working capital | -$437.00M | -$70.00M | $328.00M | -$87.00M | -$251.00M | -524.3% |
| Operating cash flow | $168.00M | $290.00M | $1.05B | $593.00M | $94.00M | -42.1% |
| Capital expenditure | -$100.00M | -$178.00M | -$134.00M | -$110.00M | -$86.00M | +43.8% |
| Investing cash flow | -$115.00M | -$2.50B | -$269.00M | -$148.00M | -$223.00M | +95.4% |
| Share buybacks | -$200.00M | -$100.00M | $0 | -$100.00M | -$100.00M | -100.0% |
| Dividends paid | -$16.00M | -$16.00M | -$16.00M | -$16.00M | -$16.00M | 0.0% |
| Financing cash flow | -$236.00M | $21.00M | -$293.00M | -$165.00M | $1.36B | -1,223.8% |
| Free cash flow | $68.00M | $112.00M | $916.00M | $483.00M | $8.00M | -39.3% |
| End cash position | $2.11B | $2.29B | $4.51B | $4.03B | $3.77B | -7.9% |
Options analytics
Put / call volume
0.50
Call-heavy session
Put / call open interest
0.64
Positioning, not flow
Max pain
66.00
+1.9% from spot
ATM implied vol
58.0%
Nearest strike to spot
Skew (10% OTM)
+10.0%
Puts bid over calls
Call volume
199
Contracts, this expiry
Put volume
99
Contracts, this expiry
Heaviest call OI
66.00
573 contracts
Heaviest put OI
64.00
114 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.04 | 1.13 | +9.1% |
| Mar 2026 | 1.05 | 0.99 | -5.7% |
| Dec 2025 | 1.40 | 1.44 | +3.0% |
| Sep 2025 | 1.05 | 1.07 | +2.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.20 | 16 | $5.35B | +4.1% |
| Next quarter | 1.59 | 14 | $5.93B | +4.2% |
| Current year | 4.93 | 20 | $21.72B | +5.3% |
| Next year | 5.41 | 20 | $22.72B | +4.6% |
Analyst targets & ownership
Mean target$82.79
High target$96.00
Low target$70.00
Implied upside27.19%
Analyst count19
ConsensusBUY
Strong buy / Buy5 / 10
Hold5
Sell / Strong sell0 / 0
Held by insiders0.37%
Held by institutions94.00%
Institutions holding1.69K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
65.65
-0.85% from price
SMA 20
65.06
-0.45% from price
SMA 50
68.89
-5.99% from price
SMA 100
66.19
-1.67% from price
SMA 200
71.11
-8.91% from price
EMA 12
65.43
-0.52% from price
EMA 26
66.34
-1.89% from price
EMA 50
67.01
-2.86% from price
RSI (14)
41.9
Neutral
MACD (12,26,9)
-0.91
Hist 0.09
ATR (14)
1.48
2.28% of price
Realised vol 30D
19.4%
Annualised
Bollinger upper
67.13
20, 2σ
Bollinger lower
62.99
20, 2σ
50 / 200 cross
Death
68.89 vs 71.11
Trend bias
Below 200
-8.91%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.76
Less volatile than market
Correlation to SPY
0.29
Largely independent
Realised vol 30D
19.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-32.5%
Peak to trough
Max drawdown 5Y
-37.4%
Peak to trough
ATR 14
1.48
2.28% of price
Beta (reported)
0.85
5Y monthly, from filing
Short interest
Shares short
16.91M
Prior 17.43M
Change vs prior
-3.0%
Shorts covering
% of float
4.24%
Normal
% of shares out
3.74%
Against total outstanding
Days to cover
6.0
Crowded exit
Float
450.20M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Oct 5, 26 | Needham | MAINTAINED | Buy | Buy |
| Sep 22, 26 | Needham | INITIATED | — | Buy |
| Sep 17, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 19, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 31, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jul 30, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 29, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 17, 26 | Hovde Group | INITIATED | — | Market Perform |
| Jul 16, 26 | UBS | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate$0.16 / yr
Forward yield0.24%
5-year avg yield—
Payout ratio3.22%
Ex-dividend dateOct 23, 2026
Next pay dateNov 13, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-22
Corporate Changes & Voting Matters
8-K · 2026-08-18
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-23
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-11
Periodic Financial Reports
10-Q · 2026-04-29
Proxy Statements
DEF 14A · 2026-03-19
Headlines
The Bull Case For GE HealthCare (GEHC) Could Change Following Imaging Software Recall And Dividend Hike – Learn Why
Simply Wall St. · 4h ago
GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal
Zacks · 13h ago
What’s News: Business & Finance
The Wall Street Journal · 23h ago
Sector Update: Healthcare Stocks Advance Late Afternoon
MT Newswires · 1d ago
GE Healthcare's Sofie Deal to Vertically Integrate Radiopharma Portfolio, Needham Says
MT Newswires · 1d ago
Sector Update: Healthcare Stocks Rise Monday Afternoon
MT Newswires · 1d ago
Sector Update: Healthcare
MT Newswires · 1d ago
GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal
Medical Device Network · 1d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.